Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Hikma's major investor to exit nearly 1 billion pound stake in drugmaker

Published 22/06/2020, 17:57
Updated 23/06/2020, 00:10
© Reuters.

© Reuters.

(Reuters) - Boehringer Ingelheim, a major shareholder in Hikma Pharmaceuticals (L:HIK), is exiting the London-listed drugmaker by selling most of its nearly one billion pound stake to institutional investors and the rest back to the company, Hikma said on Monday.

A bookrunner for the deal said Boehringer would sell 28 million shares, worth about 700 million pounds, while Hikma said it would purchase the remaining shares for not more than 295 million pounds.

Germany-based private firm Boehringer currently holds 16.45%, or roughly 40 million, of Hikma's share capital and voting rights, according to Refinitiv Eikon data, making it the drugmaker's second-biggest shareholder after Darhold Ltd.

Based on Hikma's closing price of 2,480 pence on Monday, Boehringer's stake is valued at about 992 million pounds. Hikma's overall market cap stands at 6.03 billion pounds.

The placing and buyback deals are interdependent and capped, the company said.

Hikma and Boehringer have agreed that the former would also receive a commitment fee worth 2% of the total value of the shares it will buy back.

Latest comments

They are calling the top?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.